Update On Seattle Genetics FDA Meeting

TheStreet.com's Adam Feuerstein is tweeting about the Seattle Genetics SGEN FDA meeting. Feuerstein just tweeted that the FDA panel is moving to questions and voting on Adcetris in ALCL. The FDA voted 10-0 to recommend accelerated approval of Seattle Genetics' Adcetris. Shares have been halted all day today.